A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06033950 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 13, 2023
Last Update Posted : April 17, 2024
|
Sponsor:
Colorado Prevention Center
Collaborators:
Saint Luke's Hospital of Kansas City
Bayer
Information provided by (Responsible Party):
Colorado Prevention Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2026 |
| Estimated Study Completion Date : | January 2028 |